News
Fuse Vectors Tue, Feb 25, 2025, 9:00 AM6 min read Fuse Vectors Danish biotech replaces 1980s cell-based methods with revolutionary cell-free technology, making gene therapy more accessible.
The optimized tyrosine-mutant AAV3 serotype vectors containing proapoptotic genes should prove useful for the potential gene therapy of human liver cancers.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback